AKTA avant 25

The $100K Domino Effect: Why Global CDMOs Are Blacklisting Unverified Scientific Equipment Suppliers

by
Vortex Genie 2 Mixer validation in cGMP biopharmaceutical laboratory setup by trusted Scientific Equipment Suppliers

Scientific Equipment Suppliers evaluation is no longer a simple procurement task—in 2026, it has escalated into a critical financial risk management issue for global bio-ventures and CDMOs. As the biopharmaceutical sector aggressively shifts toward complex modalities like Antibody-Drug Conjugates (ADCs), a single minor process deviation can trigger a catastrophic domino effect, leading to immediate FDA … Read more

AKTA avant 25: Top-Tier CDMO’s Downstream Purification Strategy

by
A female scientist in a white lab coat operating a Cytiva AKTA Avant 25 chromatography system for protein purification in a CDMO bioprocess facility.

The biopharmaceutical manufacturing market, particularly the CDMO (Contract Development and Manufacturing Organization) industry, is currently undergoing a massive paradigm shift. As the market’s gravity shifts from traditional monoclonal antibodies (mAb) focused on mass production to highly complex next-generation modalities such as Antibody-Drug Conjugates (ADCs), utilizing advanced platforms like the AKTA avant 25 has become a … Read more